These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11504820)

  • 1. Immunosuppression by delta-opioid antagonist naltrindole: delta- and triple mu/delta/kappa-opioid receptor knockout mice reveal a nonopioid activity.
    Gavériaux-Ruff C; Filliol D; Simonin F; Matthes HW; Kieffer BL
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1193-8. PubMed ID: 11504820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response and allogeneic mixed lymphocyte reaction in mu-, delta-, and kappa-opioid receptor knockout mice.
    Gaveriaux-Ruff C; Simonin F; Filliol D; Kieffer B
    J Neuroimmunol; 2004 Feb; 147(1-2):121-2. PubMed ID: 14741441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse agonism and neutral antagonism at wild-type and constitutively active mutant delta opioid receptors.
    Tryoen-Tóth P; Décaillot FM; Filliol D; Befort K; Lazarus LH; Schiller PW; Schmidhammer H; Kieffer BL
    J Pharmacol Exp Ther; 2005 Apr; 313(1):410-21. PubMed ID: 15590769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
    Broom DC; Nitsche JF; Pintar JE; Rice KC; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2002 Nov; 303(2):723-9. PubMed ID: 12388657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding, pharmacological and immunological profiles of the delta-selective opioid receptor antagonist HS 378.
    Spetea M; Harris HE; Berzetei-Gurske IP; Klareskog L; Schmidhammer H
    Life Sci; 2001 Aug; 69(15):1775-82. PubMed ID: 11665839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse agonism by Dmt-Tic analogues and HS 378, a naltrindole analogue.
    Labarre M; Butterworth J; St-Onge S; Payza K; Schmidhammer H; Salvadori S; Balboni G; Guerrini R; Bryant SD; Lazarus LH
    Eur J Pharmacol; 2000 Oct; 406(1):R1-3. PubMed ID: 11011049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of novel non-peptidic delta opioid receptor antagonists on human T and B cell activation.
    D'Ambrosio A; Noviello L; Negri L; Schmidhammer H; Quintieri F
    Life Sci; 2004 May; 75(1):63-75. PubMed ID: 15102522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitussive effects of naltrindole, a selective delta-opioid receptor antagonist, in mice and rats.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1993 Nov; 249(2):161-5. PubMed ID: 8287897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
    Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
    Wang D; Sun X; Sadee W
    J Pharmacol Exp Ther; 2007 May; 321(2):544-52. PubMed ID: 17267582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid diketopiperazines: refinement of the delta opioid antagonist pharmacophore.
    Bryant SD; Balboni G; Guerrini R; Salvadori S; Tomatis R; Lazarus LH
    Biol Chem; 1997 Feb; 378(2):107-14. PubMed ID: 9088539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta-1 opioid receptor dependence of acute hypoxic adaptation.
    Mayfield KP; D'Alecy LG
    J Pharmacol Exp Ther; 1994 Jan; 268(1):74-7. PubMed ID: 8301596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity of delta- and kappa-opioid ligands depends on the route of central administration in mice.
    Lunzer MM; Portoghese PS
    J Pharmacol Exp Ther; 2007 Jul; 322(1):166-71. PubMed ID: 17400888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of immune function by non-peptidic delta opioid receptor antagonists.
    House RV; Thomas PT; Kozak JT; Bhargava HN
    Neurosci Lett; 1995 Sep; 198(2):119-22. PubMed ID: 8592635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake.
    van Rijn RM; Whistler JL
    Biol Psychiatry; 2009 Oct; 66(8):777-84. PubMed ID: 19576572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites.
    Gackenheimer SL; Suter TM; Pintar JE; Quimby SJ; Wheeler WJ; Mitch CH; Gehlert DR; Statnick MA
    Neuropeptides; 2005 Dec; 39(6):559-67. PubMed ID: 16289278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.